当前位置:首页 - 行情中心 - 东宝生物(300239) - 财务分析

东宝生物

(300239)

  

流通市值:31.26亿  总市值:31.46亿
流通股本:5.90亿   总股本:5.94亿

东宝生物(300239)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.19亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益171832.70万元,未分配利润43045.85万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产259217.48万元,负债87384.77万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入188,034,307.73884,932,215.88633,112,065.92444,275,439.67
营业总成本165,982,769.88784,300,105.92555,269,833.32383,990,220.35
营业利润22,292,398.71106,181,562.9282,596,541.264,438,741.48
利润总额22,433,072.18105,632,977.381,822,795.4963,665,335.47
净利润19,044,700.7491,264,128.6471,535,188.5655,441,270.29
其他综合收益----
综合收益总额19,044,700.7491,264,128.6471,535,188.5655,441,270.29
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,210,057,294.761,234,632,290.671,325,845,585.671,447,333,237.61
非流动资产合计1,382,117,487.761,390,287,265.541,391,770,857.811,377,141,625.51
资产总计2,592,174,782.522,624,919,556.212,717,616,443.482,824,474,863.12
流动负债合计269,240,255.57323,772,083.2442,279,603.58326,246,901.57
非流动负债合计604,607,479.99561,724,206.32554,646,475.98561,644,247.12
负债合计873,847,735.56885,496,289.52996,926,079.56887,891,148.69
归属于母公司股东权益合计1,718,446,521.971,739,542,623.391,719,829,635.121,696,352,870.98
股东权益合计1,718,327,046.961,739,423,266.691,720,690,363.921,936,583,714.43
负债和股东权益合计2,592,174,782.522,624,919,556.212,717,616,443.482,824,474,863.12
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计132,755,580.06629,238,809.29472,762,196.63328,843,108.65
经营活动现金流出小计170,288,563.31560,107,691.18443,490,174.55268,704,129.73
经营活动产生的现金流量净额-37,532,983.2569,131,118.1129,272,022.0860,138,978.92
投资活动现金流入小计941,572,747.682,329,114,778.88661,893,506.91545,214,377.55
投资活动现金流出小计949,457,782.532,595,166,502.58796,460,976.35545,716,728.82
投资活动产生的现金流量净额-7,885,034.85-266,051,723.7-134,567,469.44-502,351.27
筹资活动现金流入小计40,000,0005,389,603.74,843,790.254,560,889.57
筹资活动现金流出小计44,808,713.1923,808,830.2123,803,143.322,204,686.08
筹资活动产生的现金流量净额-4,808,713.19-18,419,226.51-18,959,353.05-17,643,796.51
汇率变动对现金及现金等价物的影响-62,097.883,321.57-52,653.22-42,815.08
现金及现金等价物净增加额-50,288,829.17-215,336,510.53-124,307,453.6341,950,016.06
期末现金及现金等价物余额447,826,052.31498,114,881.48589,143,938.38755,401,408.07
TOP↑